Literature DB >> 21079046

Matrix metalloproteinases activities in hypertension: emerging opportunities.

Geert W Schmid-Schönbein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21079046      PMCID： PMC4123869          DOI： 10.1161/HYPERTENSIONAHA.110.162032

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.

Authors:  Jeffrey Odenbach; Xiang Wang; Stephan Cooper; Fung Lan Chow; Tatsujiro Oka; Gary Lopaschuk; Zamaneh Kassiri; Carlos Fernandez-Patron
Journal:  Hypertension       Date:  2010-11-15       Impact factor: 10.190

2.  Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension.

Authors:  F Lacy; D T O'Connor; G W Schmid-Schönbein
Journal:  J Hypertens       Date:  1998-03       Impact factor: 4.844

3.  Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

Authors:  Stephen F Rodrigues; Edward D Tran; Zuleica B Fortes; Geert W Schmid-Schönbein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

Review 4.  MT1-MMP: a key regulator of cell migration in tissue.

Authors:  Yoshifumi Itoh
Journal:  IUBMB Life       Date:  2006-10       Impact factor: 3.885

5.  Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.

Authors:  Merry L Lindsey; Danielle K Goshorn; Christina E Squires; G Patricia Escobar; Jennifer W Hendrick; Joseph T Mingoia; Sarah E Sweterlitsch; Francis G Spinale
Journal:  Cardiovasc Res       Date:  2004-12-13       Impact factor: 10.787

Review 6.  Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli.

Authors:  Jose A Rodriguez; Josune Orbe; Sara Martinez de Lizarrondo; Olivier Calvayrac; Cristina Rodriguez; Jose Martinez-Gonzalez; Jose A Paramo
Journal:  Front Biosci       Date:  2008-01-01

7.  Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.

Authors:  Xiang Wang; Fung Lan Chow; Tatsujiro Oka; Li Hao; Ana Lopez-Campistrous; Sandra Kelly; Stephan Cooper; Jeffrey Odenbach; Barry A Finegan; Richard Schulz; Zamaneh Kassiri; Gary D Lopaschuk; Carlos Fernandez-Patron
Journal:  Circulation       Date:  2009-04-27       Impact factor: 29.690

Review 8.  Multiphasic roles for matrix metalloproteinases after stroke.

Authors:  Anna Rosell; Eng H Lo
Journal:  Curr Opin Pharmacol       Date:  2008-01-15       Impact factor: 5.547

9.  Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator.

Authors:  Alfredo Martínez; Hae-Ryong Oh; Edward J Unsworth; Claudia Bregonzio; Juan M Saavedra; William G Stetler-Stevenson; Frank Cuttitta
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

10.  Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.

Authors:  Xiang Wang; Tatsujiro Oka; Fung L Chow; Stephan B Cooper; Jeff Odenbach; Gary D Lopaschuk; Zamaneh Kassiri; Carlos Fernandez-Patron
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190
  10 in total
  3 in total

1.  Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation.

Authors:  Ana-Maria Bosonea; Xiang Wang; Jeffrey Odenbach; Carlos Fernandez-Patron
Journal:  Drug Discov Today Dis Models       Date:  2011

Review 2.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 3.  Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension.

Authors:  Kaustav Majumder; Jianping Wu
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.